학술논문
Regulation of inflammatory diseases via the control of mRNA decay
Document Type
Academic Journal
Author
Source
Inflammation and Regeneration. March 15, 2024, Vol. 44 Issue 1
Subject
Language
English
Abstract
Author(s): Masanori Yoshinaga[sup.1] and Osamu Takeuchi[sup.1] Background The immune system employs a complex biological response known as inflammation to protect the body against harmful stimuli, infections, and tissue injuries [1, [...]
Inflammation orchestrates a finely balanced process crucial for microorganism elimination and tissue injury protection. A multitude of immune and non-immune cells, alongside various proinflammatory cytokines and chemokines, collectively regulate this response. Central to this regulation is post-transcriptional control, governing gene expression at the mRNA level. RNA-binding proteins such as tristetraprolin, Roquin, and the Regnase family, along with RNA modifications, intricately dictate the mRNA decay of pivotal mediators and regulators in the inflammatory response. Dysregulated activity of these factors has been implicated in numerous human inflammatory diseases, underscoring the significance of post-transcriptional regulation. The increasing focus on targeting these mechanisms presents a promising therapeutic strategy for inflammatory and autoimmune diseases. This review offers an extensive overview of post-transcriptional regulation mechanisms during inflammatory responses, delving into recent advancements, their implications in human diseases, and the strides made in therapeutic exploitation. Keywords: Post-transcriptional regulation, mRNA decay, Autoimmune diseases, mRNA methylation, RNA-binding proteins, Regnase family, Therapeutic intervention
Inflammation orchestrates a finely balanced process crucial for microorganism elimination and tissue injury protection. A multitude of immune and non-immune cells, alongside various proinflammatory cytokines and chemokines, collectively regulate this response. Central to this regulation is post-transcriptional control, governing gene expression at the mRNA level. RNA-binding proteins such as tristetraprolin, Roquin, and the Regnase family, along with RNA modifications, intricately dictate the mRNA decay of pivotal mediators and regulators in the inflammatory response. Dysregulated activity of these factors has been implicated in numerous human inflammatory diseases, underscoring the significance of post-transcriptional regulation. The increasing focus on targeting these mechanisms presents a promising therapeutic strategy for inflammatory and autoimmune diseases. This review offers an extensive overview of post-transcriptional regulation mechanisms during inflammatory responses, delving into recent advancements, their implications in human diseases, and the strides made in therapeutic exploitation. Keywords: Post-transcriptional regulation, mRNA decay, Autoimmune diseases, mRNA methylation, RNA-binding proteins, Regnase family, Therapeutic intervention